0001539371-22-000002.txt : 20220512
0001539371-22-000002.hdr.sgml : 20220512
20220512163153
ACCESSION NUMBER: 0001539371-22-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220512
DATE AS OF CHANGE: 20220512
EFFECTIVENESS DATE: 20220512
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kypha Inc.
CENTRAL INDEX KEY: 0001539371
IRS NUMBER: 271009575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-445500
FILM NUMBER: 22918378
BUSINESS ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 303
CITY: SAINT LOUIS
STATE: MO
ZIP: 63108
BUSINESS PHONE: 314-932-4032 EXT 313
MAIL ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 303
CITY: SAINT LOUIS
STATE: MO
ZIP: 63108
D
1
primary_doc.xml
X0708
D
LIVE
0001539371
Kypha Inc.
4340 Duncan Avenue
Suite 204
SAINT LOUIS
MO
MISSOURI
63110
314-282-2008
DELAWARE
Kentucky Pharmaceuticals, Inc.
None
Corporation
true
Chad
Stiening
4340 Duncan Avenue
Suite 204
St. Louis
MO
MISSOURI
63110
Executive Officer
Director
James
Merselis
4340 Duncan Avenue
Suite 204
St. Louis
MO
MISSOURI
63110
Director
Peter
Reinecke
4340 Duncan Avenue
Suite 204
St. Louis
MO
MISSOURI
63110
Director
Dennert
Ware
317 Limestone Creek Road
San Antonio
TX
TEXAS
78232
Director
Gerhard
Bette
4340 Duncan Avenue
Suite 204
St. Louis
MO
MISSOURI
63110
Director
Other Health Care
Decline to Disclose
- 06b
false
2022-04-08
false
true
false
1
17000000
5150000
11850000
false
13
0
0
0
false
Kypha Inc.
/s/ Chad Stiening
Chad Stiening
CEO
2022-05-12